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Primary malignant melanoma of the female urethra is a rare tumor with great agressivity and poor prognosis. We reported the case of
65-year-old woman with polypoid tumor on the external meatus of the urethra. Tumor was localy resected, and immunohistochem-
istry revealed diagnosis of malignant melanoma. After three months distal urethrectomy was performed with tumor-free margin, and
the patient is still alive during more than five years follow up period.
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INTRODUCTION
Primary malignant melanoma is one of the rarest tumors of the
female urethra. It occurs in 0.2% of all melanomas (1). Howev-
er, the urethra is the most common site of origin in primary
malignant melanoma of the genitourinary tract (2). Reed (3)
reported the first authentic case of primary melanoepithelioma of
the female urethra in 1896. Urethral melanoma shows its peak
incidence in the older age group, the average patient age being
64 years (4). The majority of the lesions have been located at the
meatus or in the distal urethra. As a rule, melanoma of the ante-
rior female urethra has a generally better prognosis than the pos-
terior or entire urethral melanoma (5). Because primary malig-
nant melanoma of the female uretha tends to metastasize at the
early stage to adjecent areas, regional lymph nodes, and occa-
sionally distant sites by the hematogenous route, the prognosis is
poor. Size of the tumor, depth of invasion (6), and the presence
of involved lymph nodes are the main prognostic factors for the
disease (7). Treatment of urethral malignant melanoma remains
an unsolved problem. Surgery, radiation and chemotherapy has
been uniformly ineffective. The relative radioresistence of
malignant melanoma and the failure of chemotherapy must be
recognized. Only eleven patients have been reported so far who
lived for 4 years or more (table 1.). In this report we describe an
additional case who is alive and well after 5 years.
CASE REPORT
A 65-year-old woman was refered by a gynaecologist due to a
urethral mass with a gross appearance of a caruncle. Upon exam-
ination a 3-cm wide, pedunculated, black pigmented, friable and
hemorrhagic polyp was found at the posterior wall of the urethral
meatus. The tumor was removed by a local excision. The
removed polyp appeared to be partly ulcerated, covered with
stratified squamous epithelium and urothelial cells. Most of the
specimen was infiltrated with tumor tissue arranged in solid
nests of non-cohesive atypic melanocytes with large hyperchro-
matic nuclei, prominent nucleoli and numerous mitoses up to 10
per high power field. Proliferating cells showed foci of fine
intracytoplasmic melanin granules (figure 1.). In addition,
HMB-45 antigen immunohistochemical stains were positive for
malignant cells, confirming that it was a malignant melanoma
(figure 2). Three months after local excision, in another institu-
tion was performed low third resection of distal urethra with no
evidence of tumor, and the patient was uneventful during 5-year-
followup period.
DISCUSSION
The histogenesis of melanomas arising in mucous membranes
still remains in dispute and several theories have been proposed.
In some animals, such as amphibians, birds, mice and rats, it has
been clearly demonstrated that melanoblats originating from the
neural rests may subsequently migrate with mesodermal cells to
sites, where they usually do not exist. A possible alternative
mechansm is the so-called ”melanogenic metaplasia” of the
epithelium, in other words metaplasia of squamous and glandu-
lar epithelium into pigment-producing cells. Finally, neural crest
elements may be transformed into melancytes and nevus cells.
Melanomas occuring in unexpected sites, such as mucous mem-
branes, can be accepted as a primary tumor only if no evidence
of any other concurrent or previously excised tumor exists. The
presence of junctional activity in the area adjecent to the lesion
is of primary impotance in this determination.
Symptoms of urethral melanomas rapidly develop and are not
distinctive. They include urethal mass, nonspecific perineal pain,
dysuria, frequency, incontinence, hematuria or local bleeding
(2). Serosanguineous vaginal discharge is often associated with
this tumor. In 75% of cases the tumor arises at the anterior wall
of the urethra and may sometimes prolapse through the exterior
urethral meatus with edema or even partial necrosis.
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TABLE 1  
Reported cases of primary malignant melanoma of female urethra with survival of 4 or more years
RT - radiation therapy; Chemo - chemotherapy; LND - lymph node dissection; AW - alive and well; AWD - alive with disease; DOD
- died of disease  
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TABLICA 1. 
Prikaz sluèajeva primarnog malignog melanoma ženske mokraæne cijevi s preživljavanjem u periodu od 4 i više godina
RT - radiation therapy / terapija zraèenjem; Chemo - chemotherapy / kemoterapija; LND - lymph node dissection / disekcija limfnih
èvorova; AW - alive and well / živ i dobro se osjeæa/izlijeèen; AWD - alive with disease / živ, ali prisutna bolest; DOD - died of dis-
ease / umro usljed bolesti  
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FIGURE 1. 
Light microscopic view of melanoma cells with intense cytoplasmic melanin pigment. HE. X 200.
SLIKA 1. 
Svjetlosno mikroskopski prikaz stanica melanoma s izraženim zrncima pigmenta melanina u citoplazmi. HE x 200.
Grossly, the tumor may be easily confused with a caruncle, hav-
ing an identical appearance. The color varies from black to blue
or brown.
The thickness of the tumor and the mitotic index have to be
taken into account on microscopic examination, since tumors
more than 1.5 mm thick and with more than one mitotic figure
in every high power field carry a worse prognosis (8).
Urethral melanoma spreads to the vulva and the vaginal wall via
the superficial lymphatics and to the inguinal lymph nodes by
means of the deep lymphatics as well as hematogenously to dis-
tant sites, such as lung, liver, bone and brain. Metastases to the
inguinal lymph nodes occur early in the course of the disease, in
50% of the cases being already present at the time of the diag-
nosis. Rapid dissemination renders treatment very difficult and
the prognosis very poor in spite of an early diagnosis. 
Despite the location that allows easy examintion, and ready
acces to biopsy and imprint cytology (9) a rate of curability is
low. This tumor usually occur in postmenopausal women and its
rarity precludes the formulation of standardized and definitive
treatment. Two problems in planning the treatment should be
recognized: local control and prevention of systemic disease.
The local control is primarily surgical. Before any decision of a
type of surgery, urethrocystoscopy should explore possible
tumor extension though the urethra toward the bladder neck.
Treatment options include local excision, urethrectomy and ante-
rior pelvic exenteration, all with or without inguinal lymph node
dissection. The operative treatments used in long-term survivors
showed no uniform tendency (table). Nissenkorn et al (10) and
Yoshida et al (11) recommended extensive operative procedures,
but despite extensive resection, only two of seven patients treat-
ed wih cystourethrectomy and anterior pelvic exenteration sur-
vived 5 years. Kim et al (5) suggested that total urethrectomy
with bilateral inguinal lymph node dissection should be the ini-
tial treatment in patients without evident distant metastases.
Despite conservative treatment, our patient is still alive after 4
years. We believe that local surgical excison can be an option in
selected patients as it retains quality of life. 
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FIGURE 2.
Cytoplasmic HMB-45 positivity on immunohistochemical staining. Fast red. X 200.
SLIKA 2. 
Pozitivno imunohistokemijsko bojenje na citoplazmatski HMB-45. Poveæanje x 200
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SAŽETAK
Primarni maligni melanom ženske mokraæne cijevi vrlo je rijedak i agresivan tumor s lošom prognozom. Prikazali smo sluèaj 65-
godišnje žene s polipoidnim tumorom na vanjskom ušæu mokraæne cijevi. Tumor je lokalno odstranjen i imunohistokemijski je
potvrðena dijagnoza malignoga melanoma. Poslije tri mjeseca uèinjena je donja uretrektomija. Rub je bio negativan na tumor i
bolesnica je živa nakon više od pet godina praæenja.
Kljuène rijeèi: lokalno odstranjenje, maligni melanom, ženska mokraæna cijev 
